Skip to content
Search

Latest Stories

RPS registers an underwhelming 7.9 per cent votes for its English Pharmacy Board election this year

The voter turnout in England for the Royal Pharmaceutical Society's (RPS) English Pharmacy Board election dropped to 7.9 per cent this year.

Out of a total of 19,512 eligible individuals, only 1,534 decided to vote.


The RPS English Board received ten nominations for five vacancies this year; therefore an election was conducted. One nomination was received for the three vacancies on the Welsh Pharmacy Board. Three nominations were received for the three vacancies on the Scottish Pharmacy Board. Therefore, no election was conducted in pharmacy boards in Wales or Scotland.

RPS president Claire Anderson said: “It’s disappointing that the voter turnout in England has dropped to 7.9 from 11.8 per cent in 2021. We have now appointed an independent review of how RPS members, elected members and stakeholders can feel more engaged and empowered to influence RPS decisions, and eagerly await its recommendations.”

The Society appointed communications agency Luther Pendragon to lead a review into how it can develop and strengthen member participation.

Commenting on the results of the elections to the three boards, Claire said: “I’m delighted to welcome our new Board members across Great Britain and look forward to working with them to champion the profession and put pharmacy at the forefront of healthcare.

“I’d like to say a big thank you to all the candidates who stood and were not elected for their courage in putting themselves forward and contributing to the debate.

“I’d also like to personally thank RPS English Pharmacy Board (EPB) member Andre Yeung for all his hard work in his additional role as RPS Treasurer."

For English Pharmacy Board, Ewan Maule, Brendon Jiang, Sharon ‘Sibby’ Buckle, Emma Boxer and Adebayo Adegbite have been elected.

Joshua Miller, Richard Shearer and Jill Swan have been elected for Scottish Pharmacy Board. Welsh Pharmacy Board  elected Liz Hallett.

RPS added, “New Board members will take up their roles at the first day of the next Board meeting for their country (Scotland 08 June, England 21 June, Wales 22 June). Andre Yeung will continue to serve as Treasurer until the next EPB meeting, and a new Treasurer will be elected by the RPS Assembly in July. In the interim, the RPS President carries out any necessary functions of the role.”

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less